Life-Sciences-Scandinavia.com
The Nordic Life Sciences Web Portal

This is a free web portal for the life sciences in the Nordic countries Denmark, Finland, Iceland, Norway and Sweden... » read more

Bühlmann Laboratories AG Appoints Christian Eberle as CEO (2025-04-08)
Dear distributors, suppliers and collaboration partners Dear customers BÜHLMANN Laboratories AG today announced the appointment of Christian Eberle as its new CEO. Christian Eberle recently worked as CEO of Bacthera AG, a Basel based contract development an...
Bico to Divest MatTek and Visikol to Sartorius for $80m (2025-04-04)
BICO Group AB (“BICO”) has entered into an agreement to divest MatTek Corp (“MatTek”) and Visikol Inc (“Visikol”) to Sartorius Lab Holding GmbH (“Sartorius”) for USD 80m, on a cash and debt-free basis. The divestment follows the Group’s updated st...
Amboss: €240m Financing Round with New Long-term Investors (2025-03-25)
AMBOSS, the leading resource for medical education and clinical decision-making in Germany and the US, closes a €240M financing round with new long-term investors, supporting the exploration of additional international markets and the expansion of its offering to...
Augustine Adds €60.2m to Close Series A at Total of €77.7m (2025-03-24)
> Novo Holdings and Jeito Capital co-led the deal, supported by Asabys Partners and existing investors > Proceeds to support the clinical development of lead candidate AGT-100216 for the treatment of Charcot-Marie-Tooth (CMT) disease, with Phase I trials startin...
AbbVie Files US Complaint against Genmab & ProfoundBio (2025-03-22)
> AbbVie Inc. files complaint against Genmab in the U.S. District Court for the Western District of Washington (Seattle) > Genmab categorically refutes allegations and will vigorously defend the company Genmab A/S (Nasdaq: GMAB) announced today that AbbVie...
[iito] Announces Major Changes in Its Social Media Strategy (2025-03-18)
> [iito] ceased all activities on Twitter/X in 2023 > All social media activities today focussed on LinkedIn > Planning for a future outside of the “big” social media platforms [iito] Business Intelligence – a Germany-based business intelligence p...
Vivesto Licenses Apealea to China’s Zhida Pharmaceutical (2025-03-18)
Vivesto AB, an oncology-focused development company, today announced it entered a licensing agreement with Zhejiang Zhida Pharmaceutical Ltd (Zhida Pharma) for the development, production and commercialization of Vivesto’s anticancer product Apealea® (paclitaxel...
Salipro Biotech & Boehringer Ingelheim: Research & License (2025-03-13)
The collaboration combines Salipro Biotech’s unique expertise and its Salipro® platform technology to stabilise challenging drug targets from Boehringer Ingelheim’s drug discovery programs to enable and accelerate the development of novel therapeutics. Sa...
Valo Therapeutics Raises €19m Investment Round (2025-03-10)
Valo Therapeutics Oy announces that it has successfully secured a financing round of €19 million, part of which was raised in Europe and part in Australia, to clinically develop its innovative immune therapy for cancer. An investment round of €13 million wa...
Callio Therapeutics: $187m Series A Led by Frazier LS (2025-03-03)
> Frazier Life Sciences launches Callio Therapeutics based on multi-payload antibody-drug conjugate technology and programs exclusively in-licensed from Singapore-based Hummingbird Bioscience > Financing led by Frazier Life Sciences with significant participatio...

Life-Sciences-Scandinavia.com is your doorway to the Nordic life sciences!

[LSS] provides free, up-to-date and structured access to

– News
– Products
– Persons
– Organisations
– Financings
– Collaborations

in the Scandinavian countries Denmark, Finland, Iceland, Norway and Sweden.

Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSS] is 100% Made in Germany!

» Start here with the latest News!

Picture Swiss Biotech Association Global Village 2025 SBD25 Basel 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)